Injections
Breast cancerLung cancer (NSCLC)Ovarian cancer
Pacli TECH
Paclitaxel Injection
Product pack shot.
A workhorse taxane chemotherapy, available in three vial sizes so hospitals can match the dose to the patient and reduce wastage.
30 mg
100 mg
260 mg
| Brand | Pacli TECH |
|---|---|
| Composition | Paclitaxel Injection |
| Dosage form | Concentrate for solution for infusion |
| Strengths | 30 mg · 100 mg · 260 mg |
| Presentation | Multi-dose vials (5 mL, 16.7 mL, 43.4 mL) |
| Therapeutic area | Breast cancer, Lung cancer (NSCLC), Ovarian cancer |
| Category | Prescription only (Rx) |
Product information
About Paclitaxel
- Microtubule-stabilising antineoplastic agent (6 mg/mL).
- Indicated in ovarian cancer, breast cancer, non-small cell lung cancer and AIDS-related Kaposi sarcoma.
- Requires dilution before intravenous infusion and premedication as per protocol.
- Store at 20–25 °C; retain in carton to protect from light.
Related products
Often supplied alongside Pacli TECH
Injections
Nab PACLITECH
Paclitaxel (Protein-bound Particles) for Injectable Suspension
Lyophilised powder for injectable suspension
100 mg
Injections
Fluoro TECH
Fluorouracil Injection
Solution for injection / infusion
500 mg1 gm
Injections
Faslo TECH
Fulvestrant Injection
Solution for injection in pre-filled syringe
250 mg / 5 mL